These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 11544330)

  • 1. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.
    Pathak MK; Yi T
    J Immunol; 2001 Sep; 167(6):3391-7. PubMed ID: 11544330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
    Yu WM; Hawley TS; Hawley RG; Qu CK
    Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses.
    Yang W; Tabrizi M; Berrada K; Yi T
    Blood; 1998 May; 91(10):3746-55. PubMed ID: 9573011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction.
    Jiao H; Yang W; Berrada K; Tabrizi M; Shultz L; Yi T
    Exp Hematol; 1997 Jul; 25(7):592-600. PubMed ID: 9216734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sodium stibogluconate on differentiation and proliferation of human myeloid leukemia cell lines in vitro.
    Pathak MK; Hu X; Yi T
    Leukemia; 2002 Nov; 16(11):2285-91. PubMed ID: 12399974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
    Aoki N; Matsuda T
    J Biol Chem; 2000 Dec; 275(50):39718-26. PubMed ID: 10993888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A negative role of SHP-2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survival.
    Chen J; Yu WM; Bunting KD; Qu CK
    Oncogene; 2004 Apr; 23(20):3659-69. PubMed ID: 15116097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.
    Kim H; Hawley TS; Hawley RG; Baumann H
    Mol Cell Biol; 1998 Mar; 18(3):1525-33. PubMed ID: 9488469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin induces tyrosine phosphorylation of a common beta subunit of GM-CSF receptor and its association with Stat5 in TF-1/TPO cells.
    Ooi J; Tojo A; Asano S; Sato Y; Oka Y
    Biochem Biophys Res Commun; 1998 May; 246(1):132-6. PubMed ID: 9600081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
    Paling NR; Welham MJ
    Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer activity of sodium stibogluconate in synergy with IFNs.
    Yi T; Pathak MK; Lindner DJ; Ketterer ME; Farver C; Borden EC
    J Immunol; 2002 Nov; 169(10):5978-85. PubMed ID: 12421984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).
    Wheadon H; Edmead C; Welham MJ
    Biochem J; 2003 Nov; 376(Pt 1):147-57. PubMed ID: 12935294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor.
    Ward AC; Oomen SP; Smith L; Gits J; van Leeuwen D; Soede-Bobok AA; Erpelinck-Verschueren CA; Yi T; Touw IP
    Leukemia; 2000 Jul; 14(7):1284-91. PubMed ID: 10914554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
    Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S
    Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of protein phosphatase 2A in the interleukin-3-stimulated Jak2-Stat5 signaling pathway.
    Yokoyama N; Reich NC; Miller WT
    J Interferon Cytokine Res; 2001 Jun; 21(6):369-78. PubMed ID: 11440634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway.
    You M; Yu DH; Feng GS
    Mol Cell Biol; 1999 Mar; 19(3):2416-24. PubMed ID: 10022928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic domains of the human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor beta chain (hbetac) responsible for human GM-CSF-induced myeloid cell differentiation.
    Matsuguchi T; Lilly MB; Kraft AS
    J Biol Chem; 1998 Jul; 273(31):19411-8. PubMed ID: 9677359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.